|
|
Volumn 30, Issue SUPPL. 2, 2009, Pages
|
|
The pharmacovigilance program on natalizumab in Italy: 2 Years of experience
a,b
g
AOU San Luigi
(Italy)
|
|
Author keywords
Multiple sclerosis; Natalizumab; Pharmacovigilance; Surveillance program
|
|
Indexed keywords
BETA INTERFERON;
GLATIRAMER;
IMMUNOMODULATING AGENT;
NATALIZUMAB;
ADENOCARCINOMA;
ADULT;
ARTHROPATHY;
ARTICLE;
BACTERIAL MENINGITIS;
CONTROLLED STUDY;
CUTANEOUS MELANOMA;
DIARRHEA;
DISABILITY;
DISEASE COURSE;
DISEASE DURATION;
DRUG FEVER;
DRUG HYPERSENSITIVITY;
DRUG INDUCED HEADACHE;
DRUG SURVEILLANCE PROGRAM;
DRUG TOLERABILITY;
DRUG WITHDRAWAL;
FLU LIKE SYNDROME;
HUMAN;
ITALY;
MAJOR CLINICAL STUDY;
MELANOMA;
MULTIPLE SCLEROSIS;
NAUSEA;
NEUROLOGIC DISEASE;
NUCLEAR MAGNETIC RESONANCE IMAGING;
RADIATION DOSE;
RELAPSE;
TONGUE ADENOCARCINOMA;
TREATMENT DURATION;
TREATMENT FAILURE;
TREATMENT RESPONSE;
UPPER RESPIRATORY TRACT INFECTION;
URINARY TRACT INFECTION;
ADULT;
ANTIBODIES, MONOCLONAL;
DATABASES, FACTUAL;
FEMALE;
FOLLOW-UP STUDIES;
HUMANS;
ITALY;
MAGNETIC RESONANCE IMAGING;
MALE;
MULTIPLE SCLEROSIS;
PATIENT DROPOUTS;
PRODUCT SURVEILLANCE, POSTMARKETING;
|
|
EID: 74049140476
PISSN: 15901874
EISSN: None
Source Type: Journal
DOI: 10.1007/s10072-009-0143-6 Document Type: Article |
|
Times cited : (11)
|
|
References (3)
|
